Transcutaneous Spinal Cord Stimulation to Promote Walking Recovery After Spinal Cord Injury - Trial NCT05982171
Access comprehensive clinical trial information for NCT05982171 through Pure Global AI's free database. This phase not specified trial is sponsored by Craig Hospital and is currently Not yet recruiting. The study focuses on Spinal Cord Injuries. Target enrollment is 30 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Craig Hospital
Timeline & Enrollment
N/A
Sep 15, 2023
Sep 15, 2024
Primary Outcome
Change in score on Walking Index for SCI (WISCI) II
Summary
The goal of this clinical trial is to investigate the effects of transcutaneous spinal cord
 stimulation (TSCS) combined with exoskeleton training, as compared to exoskeleton training
 alone to improve motor function in individuals with incomplete spinal cord injury who are 12
 months or less post-injury. Participants will be randomly assigned to a treatment group
 (exoskeleton training with TSCS, or exoskeleton training without TSCS). Participants in both
 groups will undergo a baseline evaluation, then take part in 24, 1-hour training sessions at
 Craig Hospital. After the 24 sessions have concluded, participants will undergo a
 post-treatment evaluation as well as a follow-up evaluation four weeks after training is
 completed. Researchers will compare the two groups by evaluating the following areas:
 
 - walking ability and speed
 
 - lower extremity strength, activation, and spasticity
 
 - trunk control
 
 - bowel and bladder function
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05982171
Device Trial